Try our Advanced Search for more refined results

Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.

  1. September 28, 2023

    MSN Beats Allergan's Generic Patent Row In Bench Trial

    A Delaware federal judge has found numerous patents covering Allergan's bowel treatment drug Viberzi were invalid, handing a win to Sun Pharmaceutical Industries Ltd. and MSN Pharmaceuticals.

  2. November 17, 2022

    Allergan Drops Part Of IBS Drug Patent Suit Against MSN

    Drug maker Allergan has largely dropped its patent infringement claims against competitor MSN Pharmaceuticals over a generic version of Allergan's bowel treatment drug Viberzi, according to a Thursday filing.

  3. November 14, 2022

    Sun Can't Say Allergan Used Secret Info To Grow Patent Suit

    A Delaware federal judge cleared AbbVie unit Allergan on Monday of allegations that it unlawfully used confidential information from Sun Pharmaceuticals to expand its patent suit seeking to block Sun from making generic versions of the irritable bowel syndrome drug Viberzi.

  4. November 03, 2022

    IP Forecast: VLSI Patent Battle Against Intel Goes For Round 4

    A fourth trial kicks off in Austin next week in a multibillion-dollar legal war between VLSI Technology and Intel over the licensing company's microchip technology patents. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.